Maladie de Behçet (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Maladie de Behçet" in French language version.

refsWebsite

Global rank French rank

5nih.gov

4^th place

12^th place

5wiley.com

222^nd place

129^th place

4sciencedirect.com

149^th place

80^th place

4bmj.com

1,226^th place

347^th place

3lww.com

2,769^th place

931^st place

2nejm.org

2,374^th place

298^th place

2doi.org

2^nd place

3^rd place

1parisdescartes.fr

7,928^th place

849^th place

1nature.com

234^th place

147^th place

1springer.com

274^th place

223^rd place

1orpha.net

3,537^th place

1,040^th place

1rhumato.info

low place

1wikipedia.org

low place

1ascpjournals.org

low place

1cerimes.fr

low place

1,284^th place

1tandfonline.com

507^th place

420^th place

1snfmi.org

low place

1informahealthcare.com

low place

5,838^th place

1oxfordjournals.org

1,389^th place

508^th place

1issn.org

57^th place

4^th place

ascpjournals.org

ajcp.ascpjournals.org

(en) Demirkesen C, Tüzüner N, Mat C et al. « Clinicopathologic evaluation of nodular cutaneous lesions of Behçet syndrome » Am J Clin Pathol. 2001;116:341-346

bmj.com

ard.bmj.com

Yazici H, Tüzün Y, Pazarli H et al. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome, Ann Rheum Dis, 1984;43:783-789
(en) Yazici H, Chamberlain MA, Tüzün Y, Yurdakul S, Müftüoglu A, « A comparative study of the pathergy reaction among Turkish and British patients with Behçet’s disease » Ann Rheum Dis. 1984;43:74-75
(en)Hatemi G, Christensen R, Bang D et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis, 2018;77:808-818

bjo.bmj.com

(en) Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H, « Ocular features of Behcet’s disease: an international collaborative study » Br J Ophthalmol. 2007;91:1579-1582

cerimes.fr

campus.cerimes.fr

Polycopié du Collège des Enseignants en Dermatologie de France (CEDEF), 2010-2011 (lire en ligne), Item 343 - Page 8

doi.org

dx.doi.org

(en) Keino H, Okada AA, Watanabe T, Taki W, « Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease », Eye (Lond), vol. 28, n^o 9,‎ 2014, p. 1100-6. (PMID 24946845, DOI 10.1038/eye.2014.138) modifier
Amir Hossein Faghfouri, Behzad Baradaran, Alireza Khabbazi et Mahdi Abdoli Shadbad, « Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial », International Immunopharmacology, vol. 109,‎ août 2022, p. 108825 (ISSN 1878-1705, PMID 35561480, DOI 10.1016/j.intimp.2022.108825, lire en ligne, consulté le 24 décembre 2022)

informahealthcare.com

(en) Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A et al. « Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial » Mod Rheumatol. 2009;19:542-549

issn.org

portal.issn.org

Amir Hossein Faghfouri, Behzad Baradaran, Alireza Khabbazi et Mahdi Abdoli Shadbad, « Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial », International Immunopharmacology, vol. 109,‎ août 2022, p. 108825 (ISSN 1878-1705, PMID 35561480, DOI 10.1016/j.intimp.2022.108825, lire en ligne, consulté le 24 décembre 2022)

lww.com

journals.lww.com

(en) Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y, « Behçet disease: evolution of clinical manifestations », Medicine (Baltimore), 2011;90:125-132
Calamia KT, Schirmer M, Melikoglu M, Major vessel involvement in Behçet’s disease: an update, Curr Opin Rheumatol, 2011;23:24–31
Kural-Seyahi E, Fresko I, Seyahi N et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center, Medicine (Baltimore), 2003;82:60-76

nature.com

Yazici H, Seyahi E, Hatemi G, Yazici Y, [1]Behçet syndrome: a contemporary view], Nat Rev Rheumatol, 2018;14:107-119

nejm.org

Saadoun D, Bodaghi B, Cacoub P, Behçet’s syndrome, N Eng J Med, 2024;390:640-651
Hatemi G, Mahr A, Ishigatsubo Y et al. Trial of apremilast for oral ulcers in Behçet’s syndrome, N Engl J Med, 2019;381:1918-1928

nih.gov

ncbi.nlm.nih.gov

Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T, Neutrophil activation in Behçet’s disease, Clin Exp Rheumatol, 2001;19(5 Suppl 24):S19–S24
(en) Bang D, Hur W, Lee ES, Lee S, « Prognosis and clinical relevance of recurrent oral ulceration in Behçet’s disease », J Dermatol. 1995;22:926-929
(en) Keino H, Okada AA, Watanabe T, Taki W, « Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease », Eye (Lond), vol. 28, n^o 9,‎ 2014, p. 1100-6. (PMID 24946845, DOI 10.1038/eye.2014.138) modifier
Amir Hossein Faghfouri, Behzad Baradaran, Alireza Khabbazi et Mahdi Abdoli Shadbad, « Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial », International Immunopharmacology, vol. 109,‎ août 2022, p. 108825 (ISSN 1878-1705, PMID 35561480, DOI 10.1016/j.intimp.2022.108825, lire en ligne, consulté le 24 décembre 2022)

pubmed.ncbi.nlm.nih.gov

Amir Hossein Faghfouri, Behzad Baradaran, Alireza Khabbazi et Mahdi Abdoli Shadbad, « Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial », International Immunopharmacology, vol. 109,‎ août 2022, p. 108825 (ISSN 1878-1705, PMID 35561480, DOI 10.1016/j.intimp.2022.108825, lire en ligne, consulté le 24 décembre 2022)

orpha.net

David Saadoun, « Maladie de Behçet », sur www.orpha.net Orphanet, décembre 2012 (consulté le 14 décembre 2014)

oxfordjournals.org

rheumatology.oxfordjournals.org

(en) Mat C, Yurdakul S, Uysal S et al. « A double-blind trial of depot corticosteroids in Behçet’s syndrome » Rheumatology (Oxford) 2006;45:348-352

parisdescartes.fr

biusante.parisdescartes.fr

Hippocrate (éd. Littré), Œuvres complètes, vol. 3, Paris, Baillière, 1841 (lire en ligne), p. 84.

rhumato.info

Hasna Hassikou, « La maladie de Behçet », sur www.rhumato.info, 26 octobre 2010 (consulté le 14 décembre 2014)

sciencedirect.com

(en) Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D, « New insights into the pathogenesis of Behçet’s disease », Autoimmun Rev. 2012;11:687-698
Takeuchi M, Kastner DL, Remmers EF, [https://onlinelibrary.wiley.com/doi/10.1002/art.24642 The immunogenetics of Behçet’s disease: a comprehensive review, J Autoimmun, 2015;64:137-148
(en) Miloslavsky E, Unizony S, « The heart in vasculitis » Rheum Dis Clin North Am. 2014;40:11-26
Taylor SRJ, Singh J, Menezo V, Wakefield D, McCluskey P, Lightman S, Behçet disease: visual prognosis and factors influencing the development of visual loss, Am J Ophthalmol, 2011;152:1059-1066

snfmi.org

David Saadoun (service de médecine interne et d’immunologie clinique, centre national de référence des maladies autoimmunes et systémiques rares, DHU I2B, inflammation, immunopathologie, biothérapie, UPMC, Paris VI, CHU Pitié-Salpêtrière, Paris), « Behçet (maladie de) | SNFMI », sur www.snfmi.org Société nationale française de médecine interne, juin 2014 (consulté le 14 décembre 2014)

springer.com

rd.springer.com

(en) Davatchi F, Shahram F, Chams-Davatchi C et al. « Behcet’s disease: from East to West » Clin Rheumatol. 2010;29:823-833

tandfonline.com

Tugal-Tutkun I, Onal S, Stanford M et al. An algorithm for the diagnosis of Behçet disease uveitis in adults, Ocul Immunol Inflamm, 2021;29:1154-1163

wikipedia.org

fr.wikipedia.org

(en) Keino H, Okada AA, Watanabe T, Taki W, « Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease », Eye (Lond), vol. 28, n^o 9,‎ 2014, p. 1100-6. (PMID 24946845, DOI 10.1038/eye.2014.138) modifier

wiley.com

onlinelibrary.wiley.com

de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A, HLA-B51/B5 and the risk of Behçet’s disease: a systematic review and meta-analysis of case-control genetic association studies, Arthritis Rheum, 2009;61:1287-1296
(en) Alpsoy E, Donmez L, Onder M et al. « Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study », Br J Dermatol. 2007;157:901-906
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD), The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria, J Eur Acad Dermatol Venereol, 2014;28:338-347
Saadoun D, Wechsler B, Desseaux K et al. Mortality in Behçet’s disease, Arthritis Rheum, 2010;62:2806-2812

acrjournals.onlinelibrary.wiley.com

Mirouse A, Barete S, Desbois A-C et al. Long-term outcome of ustekinumab therapy for Behçet’s Disease, Arthritis Rheumatol, 2019;71:1727-1732